A national organization representing prescription drug distributors is taking Connecticut to federal court over a new state law prohibiting excessive price increases on generic drugs.
The law, which goes into effect Jan. 1, 2026, unconstitutionally imposes “draconian penalties” on wholesale distributors if generic drug products are sold in Connecticut above the price at which the wholesaler purchased the drug from the manufacturer, the Healthcare Distribution Alliance said in its lawsuit filed Tuesday in the US District Court for the District of Connecticut.
“Though cast as a local economic regulation, the Drug Price Cap targets commerce and pricing decisions that ...